Press Release BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 4 hours ago
Press Release BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress 5 hours ago